Combivent and Aztreonam drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Combivent (albuterol sulfate; ipratropium bromide) and Aztreonam (aztreonam). Common drug interactions include parainfluenzae virus infection among females and cough among males.

The phase IV clinical study analyzes what interactions people have when they take Combivent and Aztreonam. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Combivent?

Combivent has active ingredients of albuterol sulfate; ipratropium bromide. It is often used in asthma. eHealthMe is studying from 35,341 Combivent users. Check the latest studies of Combivent.

What is Aztreonam?

Aztreonam has active ingredients of aztreonam. eHealthMe is studying from 3,054 Aztreonam users. Check the latest studies of Aztreonam.

On Jul, 11, 2026

12 people who take Combivent and Aztreonam together, and have interactions are studied.

Combivent and Aztreonam drug interactions.

What are the common drug interactions of Combivent and Aztreonam, by gender? *:

female:

Parainfluenzae virus infection
Rash
Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
Chronic kidney disease
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Hypersensitivity
Renal failure (kidney dysfunction)
Renal impairment (severely reduced kidney function)
Renal tubular necrosis (death of kidney tubules)

male:

Cough
Dyspnoea (difficult or laboured respiration)
Mania (a state of abnormally elevated or irritable mood)
Pneumonia
Pulmonary oedema (fluid accumulation in the lungs)
Sinus arrhythmia (a naturally occurring variation in heart rate that occurs during a breathing cycle)
Sputum increased
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
Chest pain
Disease progression

What are the common drug interactions of Combivent and Aztreonam, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Mania (a state of abnormally elevated or irritable mood)

40-49:

n/a

50-59:

Chronic kidney disease
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Renal failure (kidney dysfunction)
Renal impairment (severely reduced kidney function)
Renal tubular necrosis (death of kidney tubules)

60+:

Cough
Dyspnoea (difficult or laboured respiration)
Gait disturbance
Hypoxia (low oxygen in tissues)
Lung disorder (lung disease)
Pneumonia
Pulmonary oedema (fluid accumulation in the lungs)
Parainfluenzae virus infection
Rash
Sputum increased

What are the existing conditions these people have? *

Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 3 people, 25.00%
Dyspnea (difficult or laboured breathing): 3 people, 25.00%
Affective Disorder (mental disorder): 2 people, 16.67%
Bone Marrow Conditioning Regimen: 2 people, 16.67%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 2 people, 16.67%
Headache (pain in head): 1 person, 8.33%
Anaemia (lack of blood): 1 person, 8.33%
Blood Disorder: 1 person, 8.33%
Blood Pressure Abnormal: 1 person, 8.33%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Combivent and Aztreonam?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously